TRAF6 oligomerizes within the ALPK1:ADP-heptose:TIFA oligomer complex

Stable Identifier
R-HSA-9645501
Type
Reaction [binding]
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

Tumor necrosis factor (TNF) receptor-associated factor 6 (TRAF6) is a RING domain Ub ligase (E3), which, in conjunction with Ubc13-Uev1A, catalyzes K63-linked polyubiquitination that is required for activation of transforming growth factor β-activated kinase (TAK1 or MAP3K7) and IκB kinase (IKK). TRAF6 is activated downstream of alpha-protein kinase 1 (ALPK1) by binding to TRAF-interacting protein with FHA domain (TIFA) (Milivojevic M et al. 2017; Zhou P et al. 2018). TIFA recruits TRAF6 via a consensus TRAF6-binding motif of TIFA. Glycerol-gradient ultracentrifugation showed that only the high-molecular-weight forms of TIFA co-sedimented with TRAF6, suggesting that oligomerization of TIFA greatly enhanced its ability to bind to TRAF6 (Ea CK et al. 2004). In vitro ubiquitination assay in the presence of E1, Ubc13-Uev1A, purified endogenous TRAF6, Ub, and ATP showed that TIFA enhanced the Ub ligase activity of TRAF6 (Ea CK et al. 2004). Incubation of TRAF6 with wild-type or mutant TIFA proteins followed by gel-filtration chromatography showed that TIFA protein led to oligomerization of TRAF6, which eluted from the gel filtration column in the void volume (>700 kDa) (Ea CK et al. 2004). Importantly, these high-molecular-weight forms of TRAF6 displayed greatly increased Ub ligase activity as compared with TRAF6 of lower-molecular-weight species, despite a similar amount of TRAF6 protein in these fractions. Moreover, only the fraction with significantly higher Ub ligase activity of TRAF6 was able to activate IKK (Ea CK et al. 2004). The TIFA mutant that did not bind to TRAF6 was also unable to induce TRAF6 oligomerization (Ea CK et al. 2004). Cell fractionation and immunoblot analysis also suggest that TRAF6 forms oligomers in a TIFA-dependent manner in HEK293T cells in response to Shigella flexneri infection (Gaudet RG et al. 2017). Thus, upon bacterial infection such as Yersinia pseudotuberculosis, Shigella flexneri, Salmonella typhimurium or Neisseria meningitidis ALPK1 kinase activity induces TIFA oligomerization (Milivojevic M et al. 2017; Zhou P et al. 2018). The oligomerized forms of TIFA bind to TRAF6 and promote TRAF6 oligomerization (Ea CK et al. 2004). As a result, the TRAF6 Ub-ligase is activated to catalyze K63-linked polyubiquitination in conjunction with the Ubc13-Uev1A E2 complex (Ea CK et al. 2004). Activated TRAF6 promotes polyubiquitin-mediated activation the protein kinase TAK1 (MAP3K7) complex (Ea CK et al. 2004). Activated TAK1 (MAP3K7) in turn phosphorylates IkB kinase (IKK) at key serine residues within the activation loop, thereby activating IKK complex (Israël A 2010).

Literature References
PubMed ID Title Journal Year
26389808 Uncovering the Mechanism of Forkhead-Associated Domain-Mediated TIFA Oligomerization That Plays a Central Role in Immune Responses

Weng, JH, Hsieh, YC, Huang, CC, Wei, TY, Lim, LH, Chen, YH, Ho, MR, Wang, I, Huang, KF, Chen, CJ, Tsai, MD

Biochemistry 2015
Participants
Participant Of
Orthologous Events
Authored
Reviewed
Created